CD8A and T-cell non-Hodgkin lymphoma: Biological relevance of this tumor suppressor gene was first highlighted in a murine model where loss of SMARCB1 was shown to result in a highly penetrant cancer predisposition with 100% of mice developing mature CD8+ T cell lymphoma or rare rhabdoid tumors with a median onset of 11 weeks [27].